50-172-7237

UCHL5 Rabbit anti-Human, Mouse, Rat, Polyclonal, Proteintech

Manufacturer: Proteintech Group Inc

Select a Size

Pack Size SKU Availability Price
Each of 1 50-172-7237-Each-of-1 In Stock ₹ 44,150.23

50-172-7237 - Each of 1

₹ 44,150.23

In Stock

Quantity

1

Base Price: ₹ 44,150.23

GST (18%): ₹ 7,947.041

Total Price: ₹ 52,097.271

Antigen

UCHL5

Classification

Polyclonal

Conjugate

Unconjugated

Gene

UCHL5

Gene Alias

CGI 70, INO80R, Ubiquitin thioesterase L5, UCH L5, UCH37, UCHL5

Host Species

Rabbit

Purification Method

Antigen Affinity Chromatography

Regulatory Status

RUO

Gene ID (Entrez)

360853, 51377, 56207

Content And Storage

-20°C

Form

Liquid

Applications

Immunohistochemistry (Paraffin), Western Blot

Concentration

0.13 mg/mL

Formulation

PBS with 50% glycerol and 0.1% sodium azide; pH 7.3

Gene Accession No.

Q9WUP7, Q9Y5K5

Gene Symbols

UCHL5

Immunogen

UCHL5 Fusion Protein Ag2095

Quantity

150 μL

Primary or Secondary

Primary

Target Species

Human, Mouse, Rat

Product Type

Antibody

Isotype

IgG

Related Products

Img

Proteintech Group Inc

50-559-723

--

Img

Proteintech Group Inc

50-172-7527

--

Img

Proteintech Group Inc

50-173-0121

--

Img

Proteintech Group Inc

50-172-7615

--

Img

Proteintech Group Inc

50-173-0068

--

Img

Proteintech Group Inc

50-172-6540

--

Img

Proteintech Group Inc

50-173-4615

--

Img

Proteintech Group Inc

50-172-7491

--

Description

  • UCH-L5 (ubiquitin carboxyl-terminal hydrolase isozyme L5), also known as UCH37, is a 329 amino acid protein that functions to edit polyubiquinated protein substrates
  • Since UCH-L5 has the potential to rescue ubiquinated proteins, including oncogenic proteins, from proteasomal degradation, it is likely that deregulation of UCH-L5 may affect tumor growth
  • Through associations with Smad7, UHC-L5 can dramatically upregulate TGFbeta-dependent gene expression by de-ubiquinating and stabilizing TGFbeta RI
  • Also, since overexpression of UCH-L5 and other deubiquitinating enzymes has been observed in many cancer cell lines, inhibition of these proteins may be of some interest in designing therapies for cancer treatment
  • There are four isoforms of UCH-L5 that exist as a result of alternative splicing events.